Aalen-Johansen estimator was used to estimate adherence while accounting for death as a competing risk.<h4>Findings</h4>We identified 879 individuals with T1D initiating semaglutide (multiple daily injections (MDI): n = 622; insulin pump: n = 257). The gene discussed is INS; the disease is type 1 diabetes mellitus.